Middle East News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Network.

Press releases published on October 5, 2026

 شراكة كيتا تمكن شركة الدعم الدائم للخدمات اللوجستية على توسيع عمليات الخدمات اللوجستية في الدمام
Keeta Partnership Enables Dammam Logistics Provider DLC (Aldaem Aldaem Company) Scale Dedicated Rider Fleet from 20 to 61
MindWave Innovations Fecha Acordo nos EUA com a BlockAssure para o desenvolvimento e operação da AssureChain, uma Rede Completa de Seguros e Resseguros
Rasmal Ventures Partners with Türkiye’s Bilişim Vadisi to Build a Startup Bridge Between the Gulf and Türkiye
AIM ImmunoTech Highlights Recent Media Coverage of Ampligen’s® Broad-Spectrum Antiviral and Biodefense Potential
Maris-Tech Receives Pilot Order for Armored Vehicle Situational Awareness Application from a Leading Global Defense Industry
STARCARES Equips Seven Foster Homes for Children and Young People in Tanzania
Freya Biosciences named as one of Fierce Biotech’s “Fierce 15” for 2026
Kymanox Launches KymaBridge, an Intelligence Platform Connecting Pharma and Biotech Innovators with Drug Delivery Device Technologies
Beacon Therapeutics Named a “Fierce 15” Company by Fierce Biotech
Curia Invests $28 Million in Sterile API Manufacturing
Curia investiert 28 Mio. USD in die Herstellung steriler Wirkstoffe
Curia invierte $28 millones en la fabricación de API estériles
Curia investit 28 millions de dollars dans la fabrication d’API stériles
קוריה משקיעה 28 מיליון דולר בייצור רכיבים פעילים (API) סטריליים
Curia Berinvestasi $28 Juta untuk Manufaktur API Steril
キュリア、無菌API製造に2800万ドル (約44億円) を投資
Curia, 무균 API 생산에 2,800만 달러 투자
Curia Melabur AS$28 Juta dalam Pengeluaran API Steril
Curia Investe US$ 28 Milhões na Fabricação de IFAs Estéreis

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East News Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.